Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy

Stroke

Volumn 43, Issue 5, 2012, Pages 1273-1278

  Van Lammeren, Guus W ^a,b   Catanzariti, Louise M ^a   Peelen, Linda M ^a   De Vries, Jean Paul P M ^a   De Kleijn, Dominique P V ^c   Moll, Frans L ^b   Pasterkamp, Gerard ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Vascular Surgery ^*  (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Carotid endarterectomy; Major adverse cardiovascular events; Risk factors; Risk prediction; Secondary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL FEATURE; CREATININE BLOOD LEVEL; EVALUATION AND FOLLOW UP; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; COHORT STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STROKE; TIME FACTORS;

EID: 84860226198     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.647958     Document Type: Article

References (36)

1. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam study. Arterioscler Thromb. 1994;14:1885-1891.
2. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation. 1990; 82:1230-1242.
3. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372. (Pubitemid 43947981)
4. Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116:1713-1724. (Pubitemid 19015651)
5. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753. (Pubitemid 351640675)
6. Goodney PP, Likosky DS, Cronenwett JL. Factors associated with stroke or death after carotid endarterectomy in northern New England. J Vasc Surg. 2008;48:1139-1145.
7. Halm EA, Tuhrim S, Wang JJ, Rockman C, Riles TS, Chassin MR. Risk factors for perioperative death and stroke after carotid endarterectomy: results of the New York Carotid Artery Surgery Study. Stroke. 2009;40: 221-229.
8. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1999;353:2105-2110. (Pubitemid 29278479)
9. Verhoeven BA, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol. 2004;19: 1127-1133. (Pubitemid 40228502)
10. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
11. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339:1415-1425. (Pubitemid 28516064)
12. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-1502.
13. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347: 1557-1565. (Pubitemid 35315836)
15. Touze E, Warlow CP, Rothwell PM. Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke. 2006;37:2904-2909. (Pubitemid 44913856)
16. Halm EA, Hannan EL, Rojas M, Tuhrim S, Riles TS, Rockman CB, et al. Clinical and operative predictors of outcomes of carotid endarterectomy. J Vasc Surg. 2005;42:420-428. (Pubitemid 41323827)
17. World Health Organization Steps Stroke Manual: The WHO Stepwise Approach to Stroke Surveillance. Geneva: World Health Organization; 2006.
18. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009; 338:b375.
19. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.
20. Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63:721-727.
21. Akaiki H. A new look at the statistical model identification. IEEE Transactions on Automatic Control. 1974;19:716-723.
22. Gronnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal. 1996;2: 315-328. (Pubitemid 126415889)
23. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631-1660. (Pubitemid 38660414)
24. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119:3078-3084.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
26. Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biom J. 2011;53:237-258.
27. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: Gissi-Prevenzione Mortality Risk Chart. Eur Heart J. 2001;22:2085-2103. (Pubitemid 33091451)
28. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366: 29-36. (Pubitemid 40956527)
29. Sprengers RW, Janssen KJ, Moll FL, Verhaar MC, van der Graaf Y. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of Arterial Disease (SMART) cohort study. J Vasc Surg. 2009;50: 1369-1376.
30. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38:1881-1885. (Pubitemid 46847263)
31. Jamerson KA, Basile J. Prompt, aggressive BP lowering in high-risk patients. J Clin Hypertens (Greenwich). 2008;10:40-48.
32. Nissen SE. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis With Aggressive Lipid Lowering (REVERSAL) trial. Am J Cardiol. 2005;96:61F-68F. (Pubitemid 41207735)
33. Dailey G. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther. 2011;33:665-678.
34. Betancourt M, Van Stavern RB, Share D, Gardella P, Martus M, Chaturvedi S. Are patients receiving maximal medical therapy following carotid endarterectomy? Neurology. 2004;63:2011-2015. (Pubitemid 39636244)
35. van Lammeren GW, Moll FL, Blankestijn PJ, de Kleijn DP, Bots ML, Verhaar MC, et al. Decreased kidney function: an unrecognized and often untreated risk factor for secondary cardiovascular events after carotid surgery. Stroke. 2011;42:307-312.
36. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768-1777.